ORIGINAL CONTRIBUTION
Transepithelial heme-iron transport: effect of heme oxygenaseoverexpression
M. J. Mendiburo • S. Le Blanc • A. Espinoza •
F. Pizarro • M. Arredondo
Received: 9 March 2010 / Accepted: 2 November 2010 / Published online: 16 November 2010
� Springer-Verlag 2010
Abstract
Background Heme iron is found in the diet mainly in the
form of hemoglobin and myoglobin. It is known that heme
iron (heme-Fe) and inorganic iron are absorbed differently.
Intracellularly, heme oxygenase-1 (HO1) participates in the
cleavage of the heme ring producing biliverdin, CO and
ferrous iron. Iron released from heme becomes part of
labile iron pool, and it can be stored in ferritin or released
through the basolateral membrane. The mechanism by
which heme-Fe is metabolized within cells is not com-
pletely understood.
Objective This study focused on the uptake and transport
of heme iron and on the role of heme oxygenase-1 on heme
iron metabolism.
Design Caco-2 cells were incubated with different con-
centrations of heme-Fe. A full-length heme oxygenase-1
cDNA was expressed in Caco-2 cells and intracellular iron
and heme-Fe content, heme uptake, heme and iron trans-
port and heme oxygenase-1 immunolocalization were
assessed in these cells.
Results Heme-Fe was bioavailable and induced an intra-
cellular increase in iron, ferritin and HO1 levels and a
decrease in DMT1 expression. In cells overexpressing
HO1, heme-Fe uptake and transepithelial Fe transport was
higher than in controls. Most heme-Fe was metabolized to
free iron, most of which was found mainly in the basolat-
eral chamber. However, there is a fraction of heme that is
delivered intact to the basolateral side. In a high heme-Fe
condition, HO1 is found near the plasma membrane.
Conclusions These results suggest that heme oxygenase-
1 catabolizes most of the heme-Fe and favors iron influx
and efflux in intestinal cells.
Keywords Heme-Fe � Transepithelial transport �Caco-2 cells � Heme oxygenase
Introduction
One of the defense mechanisms most widely used in nature
is enzyme heme oxygenase-1 (HO-1). This microsomal
enzyme performs the seemingly lackluster function of
catabolizing heme to generate bilirubin (an antioxidant),
carbon monoxide, and free iron (a potent pro-oxidant) [37].
Three heme oxygenase (HO) isoforms have been identified,
HO-1, HO-2, and HO-3. HO-1 is a 32-kDa heat shock
protein, which is inducible by numerous noxious stimuli.
The common characteristic of many of these inducers is
their ability to cause oxidative stress. These include, but are
not limited to: heme and heavy metals [14], hyperoxia [24],
hypoxia [7, 25], UV light, hydrogen peroxide [19, 23],
lipopolysaccharide [5], hyperthermia [13] and endotoxin
[6]. HO-1 expression is primarily regulated at the tran-
scriptional level [1, 9, 11, 15]. HO-2 is a constitutively
synthesized 36-kDa protein, which is abundant in brain and
testis [36, 39]. The third isoform, HO-3, has been reported
as a pseudogene derived from HO-2 transcripts [17].
Remarkably, the activity of this enzyme results in pro-
found changes in the ability of cells to protect themselves
against oxidative injury. HO-1 has been shown to have
anti-inflammatory, anti-apoptotic, and anti-proliferative
effects, and it is now known to have salutary effects in
diseases as diverse as atherosclerosis and sepsis. Stocker
[35] has proposed that this enzyme might provide cellular
M. J. Mendiburo � S. Le Blanc � A. Espinoza � F. Pizarro �M. Arredondo (&)
Micronutrient Laboratory, Nutrition Institute and Food
Technology, El Lıbano 5524, Macul, Santiago, Chile
e-mail: [email protected]
123
Eur J Nutr (2011) 50:363–371
DOI 10.1007/s00394-010-0144-5
protection. The mechanism by which this enzyme confers
cellular protection is only beginning to be unraveled. The
appeal is readily apparent: if we can understand how cells
are able to protect themselves from oxidative stress, then
our understanding and ability to intervene in disease pro-
cesses will be immeasurably advanced [28].
Both HO and its substrate, heme, are highly conserved
molecules across almost all forms of life, from algae to
mammals. Molecules so evolutionarily conserved and
ubiquitous generally serve a necessary and fundamental
purpose [28]. There are relatively few studies describing
the mechanism of intestinal heme iron absorption despite
the importance of heme iron as a highly bioavailable source
of dietary iron. Populations that consume meat as a sig-
nificant component of their diet are normally iron replete.
In fact, it has been determined that two-thirds of absorbed
dietary iron in North America and Europe is derived from
heme iron, although it only comprises one-third of dietary
iron. Intestinal absorption of heme iron is higher than that
of non-heme iron, suggesting that heme may be a preferred
iron source in iron deficiency; it may also be a source of
dietary iron to avoid when iron status is high, such as in
hemochromatosis [31]. In this study, we determined the
effect of HO1 over-expression on heme-Fe bioavailability
and intracellular iron transport.
Materials and methods
Cell culture
Caco-2 cells (American Type Culture Collection HTB37
Rockville, MD) (1 9 105 cells) were cultured at 37 �C and
5% CO2 in 25-cm2 flasks with Iscove0s media (Gibco Life
technologies, Grand Island, NY) supplemented with 10%
FBS, 10 kU/L penicillin/streptomycin, and 25 mg/L fun-
gizone (Gibco). The cells were trypsinized and re-seeded in
either 24- or in 6-well plates (0.2–0.5 9 105 cells) or on
polycarbonate membranes of 0.33 lM pore size and
6.5 mm diameter (0.2 9 105 cells) (Transwells, Corning,
Costar, Cambridge, MA). The medium was changed every
2–3 days.
Isotopic labeling and digestion of hemoglobin (Hb)
An iron isotope (55Fe) of high specific activity was used as
a tracer (NEN, Life Science Products, Boston, MA).
Labeled hemoglobin (Hb) was prepared from red blood
cells obtained from New Zealand rabbits that had received
an intravenous injection of 74 MBq of 55Fe as ferric citrate
diluted in saline solution. The rabbits were bled through a
cardiac puncture 15 days later. The radioactive red blood
cells were centrifuged (1,0009g for 15 min at 22 �C) and
washed with saline solution, then hemolyzed by freezing
and dehydrated by lyophilization. The cell extract was
labeled with a specific activity of 2,460 kBq of 55Fe per mg
of heme-Fe obtained. Partial digestion of Hb solution was
performed. Briefly, Hb solution containing 2 mM 55Fe or56Fe were digested with 0.1% pepsin at pH 2.0 for 1 h at
37 �C. This solution was diluted by adding HEPES buffer
(pH 7.2) to increase the pH to 6.8. A digestion of 52 ± 3%
was estimated in the Hb-digest by measuring Hb content in
the supernatant, which was used as a source of heme-Fe.
Elemental Fe was determined by atomic absorption
spectrometry with graphite furnace (SIMAA 6100, Perkin-
Elmer, Norwalk, CT).
Caco-2 cells with different heme or non-heme iron
concentrations
Caco-2 cells were grown for 7 days in the presence of
heme-Fe, as described earlier. The incubations were made
using a stock heme-Fe solution with the following con-
centrations: 0.1, 5, 10, 20, and 50 lM of heme-Fe. The
medium was changed every 2–3 days. After 7 days, the
cells were trypsinized and re-seeded (5–10% initial
cells = 1 9 105), as previously described, for another
7 days. After the treatment, a cell lysate was prepared with
lysis buffer (in mM: 10 HEPES, pH 7.5, 3 MgCl2, 40 KCl,
1 PMSF, 1 DTT, and 5% glycerol, 0.5% Triton X-100 and
1 9 protease inhibitor cocktail (Sigma, St Louis, MO). The
mix was incubated for 15 min on ice and centrifuged for
10 min at 4 �C and 15,000 rpm. The supernatant was ali-
quoted and stored at -70 �C. Protein concentration was
determined by Lowry method [26], intracellular ferritin by
ELISA (rabbit anti-human ferritin code A0133 and per-
oxidase-conjugated rabbit anti-human ferritin code P0145,
Dako Corp, Denmark) and total iron by spectrometric
atomic absorption with graphite furnace (SIMAA 6100,
Perkin-Elmer, Norwalk, CT).
Antibodies and immunodetections
Western blotting assays were performed on cell lysate to
study the expression of HO-1, DMT1 (Divalent Metal
Transporter 1) and Ireg1 (also, ferroportin). Fifty micro-
grams of cell lysate were loaded and separated on 14%
(HO-1) and 8% (DMT1 and Ireg1) SDS–PAGE, and trans-
ferred to a nitrocellulose membrane. The primary antibody
for HO1 was a rabbit polyclonal antibody (Santa Cruz Bio-
technology, Inc). DMT1 and Ireg1 antibodies were provided
by Dr. MT Nunez, Faculty of Science, University of Chile.
DMT1 and Ireg1 antibodies were rabbit polyclonal anti-
bodies prepared against COOH-terminal peptide. The sec-
ondary antibody was peroxidase-labeled goat anti-rabbit
immunoglobulin G (Sigma Chemical). For membrane
364 Eur J Nutr (2011) 50:363–371
123
examination, the enhanced chemiluminescence Western
blotting detection system (Amersham, Arlington Heights,
IL) was used. Membranes were stripped with 100 mM citric
acid (pH 3.0) and then re-blotted with anti-actin (Sigma
Chemical).
Subcellular localization of HO1 in Caco-2 cells
Cells were grown in polyester membrane Transwells
(Costar) for 14 days, incubated with or without 50 lM
heme-Fe for the last 5 days, then fixed with 4% parafor-
maldehyde, permeated with 0.2% Triton X-100 in saline,
and reacted with anti-HO1 antibody. A second antibody
was FITC-labeled anti-rabbit IgG antibody (Sigma Chem.
Co.). Fluorescence was determined in a Zeiss MP40 con-
focal microscope. For co-immunolocalization analysis,
cells were incubated over night with mouse anti-HO1
(1:250, US Biological) and rabbit anti-Glut1 (1:200, US
Biological). Then, cells were washed 69 with PBS-BSA
for 5 min and then incubated with Alexa 546 anti-mouse
IgG (1:500, Molecular Probes) and Alexa 488 anti-rabbit
IgG (1:500, Molecular Probes). Fluorescence was deter-
mined as mentioned earlier.
Vector construction and transfection of Caco-2 cells
with ho1 cDNA
Total RNA was isolated from Caco-2 cells with Trizol
reagent (Invitrogen) according to manufacturer instruc-
tions. Briefly, Caco-2 cells seeded in 25-cm2 bottles were
cultured for 7 days and lysed with 2.5 mL of Trizol. RNA
was resuspended in DEPC water, aliquoted and stored at
-80 �C. cDNA was obtained by reverse transcription. The
reaction contained 5 lg of RNA and 0.5 lg oligo-dT. The
mix was incubated at 70 �C for 10 min and then at 4 �C for
1 min. Two microliters of 109 PCR buffer, 1 lL of
50 mM MgCl2, 1 lL of 10 mM dNTPs, and 2 lL of 0,1 M
DTT were added to a final volume of 20 lL and incubated
at 42 �C for 5 min. Then 200 U of MMLV Reverse
Transcriptase (Invitrogen Corporation, Carlsbad, CA,
USA) was added, and the mix was incubated at 42 �C for
50 min. The reaction was stopped by incubation at 70 �C
for 15 min. One microliter of RNase H (Invitrogen) was
added, and the mix was incubated at 37 �C for 20 min.
ho1 full-length cDNA (GenBank accession number:
NM_002133) was amplified by PCR using the following
primers: HO1s 50-GAACGAGCCAAGCTTCGGCCGGAT
G-30 (position 59-83) and HO1a 50-GGAGCCAGCGC
GGCCGCATACACAT-30 (position 942-966). Underlined
letters indicate nucleotide changes with respect to the ho1
mRNA sequence in order to introduce restriction sites for
HindIII and NotI. The cDNA was used as a template
for PCR amplification using the following cycles: 94 �C
for 35 min, 94 �C for 15 seg, 60 �C for 1 min, 72 �C for
1 min, and 72 �C for 10 min. A band of 908 pb was
obtained. The PCR product was digested with HindIII and
NotI and purified with Gene Clean II Bio 101 using silica
(Sigma–Aldrich, St Louis, MO). ho1 cDNA was cloned in
the pcDNA3.1myc-his (Invitrogen) expression vector.
E. coli DH5a were transformed, and positive clones were
verified with restriction analysis and sequencing. Caco-2
cells were grown at subconfluence (50–70%) and trans-
fected with pcDNA3.1myc-his-ho1 vector (HO1 cells) or
pcDNA3.1myc-his (control cells) using Lipofectamin
2000 (Invitrogen). Transfected cells were selected using
800 lg/mL G418 (Gibco) for 48 h, and then the cells were
maintained in Iscove0s media as earlier with 400 lg/mL
G418.
Intracellular total levels of iron and ferritin
HO-1 and control cells were grown in 12-well plates in
selection medium for 7 days. A cell lysate was prepared,
then digested with 65% nitric acid (1:1) and incubated at
60 �C overnight. Total iron was determined by spectro-
metric atomic absorption with graphite furnace Simaa 6100
(Perkin Elmer). Intracellular ferritin was determined in cell
lysate using ELISA (rabbit anti-human ferritin Code A0133
and peroxidase-conjugated rabbit anti-human ferritin code
P0145, Dako Corp, Denmark).
Heme-Fe and iron uptake and transport
HO1 and control cells were plated onto 0.33 cm2 poly-
carbonate inserts for 12 days and grown as previously
described. The medium was changed every 3 days. Inserts
were used when they attained stable resistance values
between 250 and 280 X cm2. On the day of the experiment,
the cells were washed with 19 PBS, and 50 lM heme-55Fe
or 25 lM 55FeCl3 (Fe:ascorbic acid 1:5) was added to the
apical side in transport buffer (in mM: 50 MOPS-Na; 94
NaCl; 7.4 KCl; 0.74 MgCl2; 1.5 CaCl2; 5 glucose, pH 6.5)
at different times (0–60 min) at 37 �C. The reaction was
stopped washing the inserts 3 times with cold PBS/1 mM
EDTA. Afterward the membranes were cut out and 1 mL
of scintillation liquid was added to each tube. Also, 100 lL
of the basolateral medium was diluted with scintillation
liquid. The radioactivity from 55Fe in both the membrane
and the basolateral medium was measured in a gamma
counter (Beckman LS 5000 TD).
Determination of non-heme iron and protoporphyrin
transport at the basolateral side
For protoporphyrin transport determination, HO1 and con-
trol cells were grown in bicameral chambers (0.66 cm2) in
Eur J Nutr (2011) 50:363–371 365
123
Iscove0s media with 10% low-Fe FBS and G418
(400 lg/mL). On the day of the experiment, 50 lM heme-Fe
was added to the apical chamber, and the cells were incu-
bated at 37 �C for different periods of time (0–60 min). The
transepithelial electric resistance (TEER) was monitored
during the experiment. Inserts with TEER lower than
240 X cm2 were eliminated. Basolateral media was col-
lected and protoporphyrin concentrations were measured in
a Shimadzu UV-1601 spectrophotometer at 398 nm. We
used a molar extinction coefficient of e = 1.56 9 105 M-1
cm-1 for this calculation. For non-heme iron transport
determination, control and HO1 cells were grown in
bicameral inserts (1 cm2). On the day of the experiment,
inserts were washed with MOPS-saline buffer. Afterward,
0.1 lM calcein in MOPS-glucose buffer and MOPS-glucose
were added to the basolateral and apical chamber, respec-
tively. Calcein fluorescence was measured, then heme-Fe
(10 lM) was added to the apical compartment and the
decrease in fluorescence was measured again in 30 cycles of
1 min each. Finally, 10 lL of 10 lM SIH were added to
chelate Fe.
Heme oxygenase enzymatic activity
A cell lysate from control and HO1 cells was prepared using
a non-denaturing lysis buffer (20 mM Tris–HCl; pH 7.4;
0.5% Triton X-100; protein inhibitor cocktail). Two hundred
fifty micrograms of cell lysate were incubated with 600 lL
of B buffer (100 mM KH2PO4, pH 7.4), 100 lL of 150 lM
hemin, 100 lL of 100 lg/mL rat liver extract containing
biliverdin reductase and 100 lL of 10 mM NADPH for 1 h
at 37 �C in the dark. Bilirubin formed in the reaction was
extracted with 1 mL of chloroform for 1 h at room temper-
ature in a shaker (100 rpm). Then, absorbance was measured
at 530 nm (molar extinction coefficient of bilirubin:
43.5 mM-1 cm-1). HO enzymatic activity was expressed as
nmole of bilirubin/mg protein/hr.
Bilirubin reductase isolation
Rat livers (Rattus norvegicus) were perfunded in situ with
saline (0.9% NaCl, pH 7.2) until complete discoloration,
dissected, homogenized in lysis buffer A (0.1 M sodium
citrate, pH 5.0; 10% glycerol) and centrifuged for 20 min
at 10,0009g and 1 h at 105,0009g. The supernatant was
diluted in 20 mM KH2PO5; 135 mM KCl; 0.1 mM EDTA;
pH 7.4. Protein concentration was determined. The extract
was aliquoted and stored at -20 �C.
Statistical analysis
Variables were tested in triplicate, and the experiments were
repeated at least twice. Variability among experiments was
\20%. One-way ANOVA and T test were used to test dif-
ferences in mean values, and Bonferroni0s post hoc test was
used for comparisons (SAS 8.0E, SAS Institute Inc., Cory,
NC). Differences were considered significant if p \ 0.05.
Results
Intracellular iron and ferritin content in Caco-2 cells
incubated with heme-Fe
To determine the bioavailability of heme-Fe, we measured
total intracellular iron (Fig. 1a) and ferritin (Fig. 1b) in
Caco-2 cells incubated with different extracellular heme-Fe
concentrations for two passages. Intracellular Fe increased
(2.8 ± 0.4–10.8 ± 0.8 nmole Fe/mg protein) when extra-
cellular heme-Fe increased from 0.5 to 100 lM (one-way
ANOVA: p \ 0.001). Intracellular ferritin also increased
(1.3 ± 0.2–43.6 ± 0.6 nmole Fn/mg protein) in the same
range of extracellular heme-Fe (one-way ANOVA:
p \ 0.001). HO1 expression was induced at high extra-
cellular heme-Fe concentrations (p \ 0.01). As expected,
DMT1 expression decreased when intracellular Fe
increased (p \ 0.05). No change was observed in Ireg1
expression (Fig. 1c, d).
Immunolocalization of heme oxygenase
To determine the intracellular localization of HO1 enzyme,
Caco-2 cells were incubated with or without 50 lM heme-
Fe for 5 days and subjected to confocal microscopy. In
Caco-2 cells incubated with heme-Fe, HO1 changed its
localization from perinuclear to a domain close to the
plasma membrane (Fig. 2A:a) compared with control cells
(Fig. 2A:c). To confirm this result, a co-immunolocaliza-
tion was performed in cells incubated with GLUT1 (2B:a)
and HO1 (2B:b) antibodies. We observed that HO1 co-
localizated with GLUT1 transporter (a basolateral marker
in Caco-2 cells), which suggests that HO1 could be asso-
ciated to an inner plasma membrane domain.
Characterization of Caco-2 cells over-expressing HO1
To enhance the expression of HO1, Caco-2 cells were
transfected with pcDNA3.1myc-his-ho1 vector (HO cells),
and HO1 overexpression was confirmed by Western blot-
ting (Fig. 3a). Under this condition, HO1 enzymatic
activity increased from 6.4 ± 2.1 to 10.2 ± 0.4 nmole
bilirubin/hr/mg protein, in control and HO1 cells, respec-
tively (p \ 0.05; Fig. 3b). Intracellular ferritin concentra-
tion also increased from 0.9 ± 0.1 to 6.4 ± 1.9 ng ferritin/
mg protein, in control and HO1 cells, respectively
(p \ 0.01, Fig. 3c).
366 Eur J Nutr (2011) 50:363–371
123
Heme-Fe and non-heme iron uptake and transport
in HO cells
To determine the effect of HO1 over-expression on heme-
Fe and iron uptake, HO1 cells seeded in bicameral inserts
were incubated with 50 lM heme-55Fe or 25 lM 55FeCl3added to the apical side, and radioactivity from the cell
lysate and basolateral medium was measured to determine
heme-Fe or iron uptake and iron transport, respectively.
HO1 cells showed an increase in heme-Fe uptake
(p \ 0.02) (Fig. 4a) and transport of 55Fe to the basolateral
side, compared with control cells (p \ 0.01) (Fig. 4b).
There were no significant changes in apical non-heme iron
uptake or apical to basolateral iron transport.
Apical to basolateral protoporphyrin and iron transport
in HO cells
To elucidate which form of iron (i.e. heme-Fe or ferrous
Fe) is the main contributor of apical to basolateral 55Fe
transport, heme (as a protoporphyrin) and non-heme iron
were measured from the basolateral side after HO1 cells
were incubated with 50 lM heme-Fe apically. Transport of
protoporphyrin was significantly lower in HO1 cells com-
pared to control cells (p \ 0.001) (Fig. 5a). However, iron
transport to the basolateral side, measured by calcein
quenching, was higher in HO1 cells than in control cells
(one-way ANOVA: p \ 0.02) (Fig. 5b).
Discussion
The process of non-heme-Fe absorption by enterocytes is
very well known [4, 10, 30, 34]. However, there are few
studies regarding heme-Fe uptake and transport by intes-
tinal cells. The movement of heme into and within cells
was thought to occur by diffusion. However, the chemical
properties of heme make diffusion too slow to keep pace
with biological processes [21]. It has been suggested that
heme enters cells as an intact molecule of metalloporphyrin
[33], and three different mechanisms have been proposed
for heme uptake: (1) pinocytosis [29, 42], (2) heme
receptor on duodenal brush border [16] and (3) via the
heme transporter HCP1 (heme carrier protein 1) [32],
whose activity should be closely related to heme oxygenase
enzyme. Iron released from heme is later found in the
blood [10, 40, 41]. However, the mechanism of intracel-
lular heme movement from apical to basolateral side has
yet to be explained.
Heme-Fe was bioavailable for Caco-2 cells when they
were incubated with different heme-Fe concentrations.
Similar to what is observed in Caco-2 cells incubated with
Intracellular Fe
-1
10
12
Intracellular Ferritin
-1
30
40**
nmol
e F
e* m
g pr
otei
n2
4
6
nmol
e F
erri
tin
*mg
prot
ein
10
20
Extracelular Heme-Fe, uM0 10 50 100
Extracelular Heme-Fe, uM0 10 50 100
*
HO1
Actin
0 10 20 40 60 100
DMT1
Heme-Fe,µM Heme-Fe,µM
1.4
1.6
1.810204060
100
*
Actin
DMT1
Ireg1
Actin
prot
ein/
acti
n, A
U
0.8
1.2
1.0
*HO1 DMT1 IREG1
8
A B
C D
Fig. 1 Caco-2 cells were
incubated with different heme-
Fe concentration (range
0–100 lM). Intracellular total
Fe was measured by
spectrometric atomic absorption
with graphite furnace Simaa
6100 (a), ferritin by ELISA (b),
Western blot of HO1, DMT1,
and Ireg1 (c) and densitometric
analysis of C (d). (*One-way
ANOVA, p \ 0.001)
Eur J Nutr (2011) 50:363–371 367
123
non-heme iron [2], in cells incubated with heme-Fe, total
intracellular iron and intracellular ferritin concentration
increased. Furthermore, HO1 protein expression was
dependent of heme-Fe bioavailability, as we had previously
shown [3]. As a result of the increased intracellular Fe,
DMT1 transporter expression decreased. However, Ireg1
protein expression did not change in the present experi-
mental conditions. These results indicate that heme-Fe was
available for the cell and that once iron is released it
becomes part of the intracellular Fe pool. Similar results
have been shown by Eisenstein et al. [12], who observed
that release of iron from heme is necessary for maximal
induction of ferritin synthesis and that direct donation of
iron to the intracellular iron pool induced ferritin synthesis
significantly, but it was not a good inducer of HO. In
humans, Pizarro et al. [31], demonstrated that heme-Fe
absorption is a saturable process post-ingestion of physio-
logical doses of either hemoglobin or myoglobin.
To determine the role of HO1 enzyme on intracellular
iron transport, we transfected Caco-2 cells with the HO1
cDNA. We observed an increase in HO1 protein expression
and enzymatic activity and in intracellular ferritin con-
centration in these cells. The increase in ferritin concen-
tration is an indicator of increased iron availability. Under
Fig. 2 Cellular HO1
distribution in Caco-2 cells.
a Caco-2 cells were reacted with
anti-HO1 antibody followed by
FITC-labeled anti-rabbit IgG
antibody as described in
Methods (A and C). Caco-2 cells
were incubated with (A) or
without (B) 50 lM heme-Fe for
5 days. HO1 localization was
assessed following FITC
fluorescence in a confocal
microscope. Phase contrast of
Caco-2 cells (B and D)
(b) Co-immunolocalization of
HO1 and GLUT1 transporter.
Caco-2 cells were incubated
with rabbit anti-GLUT1 (A) and
mouse anti-HO1 (B). Then cells
were incubated with Alexa 546
anti-mouse IgG and Alexa 488
anti-rabbit IgG. Fluorescence
was determined as mentioned
earlier
368 Eur J Nutr (2011) 50:363–371
123
these conditions, heme-Fe uptake by HO1 cells was
increased, which correlated positively with iron availabil-
ity. This result suggests that in HO1 cells, which show a
high HO1 enzymatic activity, the catabolism of intracel-
lular heme is enhanced, resulting in a decrease in the
intracellular heme/non-heme-Fe ratio. This is an indication
that HO1 cells have a higher activity than controls cells
that results in a decrease in heme transport and an increase
in iron transport. Furthermore, the over-expression of HO1
triggers an increase in heme uptake, but does not modify
non-heme-Fe uptake, which also suggests that the intra-
cellular heme levels in these cells are lower, leading to a
compensatory increment in heme uptake. The latter is
possibly due to an up-regulation of the expression of a
heme importer. Taken together, these results suggest that
the increase in intracellular ferritin is due to an increase in
heme uptake. In HO cells, heme-Fe uptake and apical to
basolateral iron transport were higher than in control cells.
Independent of iron concentration, the cells exposed to
heme-Fe transported iron out of the cell at a higher rate.
Enzymatic activity of HO
*
-1
88
Intracellular Ferritin
-1
0.06
0.08
0.10
-1
4
6
4
6
**HO1
Actin
HO1Control
nmol
e bi
lirru
bin
* m
g pr
otei
n
0.02
0.042
Control
2
* h
Control HO1
ng F
erri
tin
* m
g pr
otei
n
HO1
A B C
Fig. 3 Caco-2 cells were transfected with HO1 cDNA (HO1 cells). a HO1 Western blot in HO1 cells and control cells; b heme oxygenase
activity; and c intracellular ferritin concentration. (T test: *p \ 0.01; **p \ 0.001)
300ControlHO1
Apical Heme-
100ControlHO1
Apical to Basolateral 55 Fe transport
*
150
200
250 *
60
80
-1
50
100
20
40
mg
prot
ein
600
800
80
100
mol
e 55F
e *
Control
HO1Control
HO1
40040
60
p
-1 m
g pr
otei
nm
ole 55
Fe *
p
10 20 30 40 50 60Time, min
10 20 30 40 50 60
20
Time, min Apical
55Fe uptake Apical to Basolateral
55Fe transport
55Fe uptake
200
A
C
B
D
Fig. 4 Heme-Fe uptake (a) and
apical to basolateral Fe transport
(b) in HO1 cells and control
cells. Caco-2 cells were
incubated at 37 �C for 0–60 min
with 10 lM heme-55Fe.
Radioactivity was measured in
membranes and in basolateral
media, (*two-way ANOVA,
p \ 0.001)
Eur J Nutr (2011) 50:363–371 369
123
It has been proposed that cells exposed to heme-Fe cannot
sense iron uptake [8, 38]. However, as we were following55Fe, we cannot discriminate which form of iron (heme-Fe
or Fe) was transported to the basolateral side.
We also studied whether heme is transported to the
basolateral side. The results suggest that most of the heme-
Fe was catabolized in the HO1 cells. However, a propor-
tion of heme-Fe (as protoporphyrin) is transported intact to
the basolateral side (control cells). Free heme and proto-
porphyrin are toxic to the cell; therefore, cells must balance
their intracellular metabolism, and for this reason free
heme must be transported out of the cells. This transport
could be performed by FLVCR (Feline Leukemia Virus
subgroup C Receptor) [18]. FLVCR protects erythroid cells
from heme toxicity during differentiation. This heme-efflux
protein is expressed in other cells and tissues, including the
intestine, where they appear to function as apical/basolat-
eral heme exporters to prevent toxicity within the entero-
cytes [22, 32]. In this study, iron in the basolateral media
was threefold higher in HO1 cells than in control cells.
Heme oxygenase-1 distribution in control cells was
mainly perinuclear, which corroborates previous results
from this group [27]. However, in cells incubated with heme-
Fe, the expression of HO1 was higher and detected at a
peripheral compartment. In Caco-2 cells that were over-
expressing HO1, the intracellular localization of HO1
changed from a perinuclear to a putative plasma membrane
topology. Kim et al. [20], using inducers of HO1 or over-
expression of HO1, demonstrated an increase in HO1 protein
in a detergent-resistant fraction containing caveolin-1.
Inducible HO activity appeared in plasma membrane,
cytosol, and isolated caveolae. HO1-GLUT1 co-localization
suggests a basolateral localization of HO1 in Caco-2 cells.
However, it is necessary to take into account that most of the
membrane surface in these cells corresponds to a basolateral
membrane. It is probably that HO1 is associated to a struc-
ture that itself interacts with the plasma membrane. Further
experiments are necessary to dilucidate this question.
In summary, our study shows that Caco-2 cells can be
used as a model to study intestinal heme-iron metabolism
when high specific activity heme 55Fe is used. Heme-Fe is
taken up by the cells, mostly degraded by HO1, and free
iron forms part of the labile iron pool, which is delivered
either to ferritin or to the basolateral side. A fraction of
heme can be transported out of the cells intact.
Acknowledgments This work was supported by Fondo Nacional de
Ciencia y Tecnologıa, grant 1085173 to MAO.
References
1. Agarwal A, Shiraishi F, Visner GA, Nick HS (1998) Linoleyl
hydroperoxide transcriptionally upregulates heme oxygenase-1
gene expression in human renal epithelial and aortic endothelial
cells. J Am Soc Nephrol 9:1990–1997
2. Arredondo M, Orellana A, Nunez MT (1997) Intracellular iron
regulates iron regulatory protein activity and iron absorption in
intestinal epithelial (Caco-2) cells. Am J Physiol 273(36):G275–
G280
3. Arredondo M, KIoosterman J, Nunez S, Segovia F, Candia V,
Flores S, Le Blanc S, Olivares M, Pizarro P (2008) Heme iron
uptake by Caco-2 cells is a saturable, temperature sensitive and
modulated by extracellular pH and potassium. Biol Trace Elem
Res 125:109–119
4. Beard JL, Dawson H, Pinero DJ (1996) Iron metabolism: a
comprehensive review. Nutr Rev 54:295–317
Fe FeFe
Fe Fe
Fe
Fe
Fe
398 nm
-1 Control
Fe
CalceinSIH
Fe
Fe -SIHFeFe
300
400
500 HO1
80
100SIH
Heme-Fe
*
100
200
Flu
ores
ccen
ce, %
40
60
Control *
Apical-basolateral heme transportTime, min
pmol
e pr
otop
oorp
hyri
n *
ml
10 20 30 40 50 60
Time, min0 10 20 30 40
HO1
Apical-basolateral Fe transport
Fe Fe
A BFig. 5 Apical to basolateral
heme transport (a) and apical to
basolateral Fe transport. Caco-2
cells were cultured in bicameral
chambers and incubated with
heme-Fe in the apical side.
Heme (a) and Fe (b) transport
was measured in the basolateral
chamber. (*Two-way ANOVA,
p \ 0.001)
370 Eur J Nutr (2011) 50:363–371
123
5. Camhi SL, Alam J, Otterbein L, Sylvester SL, Choi AM (1995)
Induction of heme oxygenase-1 gene expression by lipopolysac-
charide is mediated by AP-1 activation. Am J Respir Cell Mol
Biol 130:387–398
6. Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA (1998)
Induction of ferritin and heme oxygenase-1 by endotoxin in the
lung. Am J Physiol Lung Cell Mol Physiol 275:L583–L592
7. Carraway MS, Ghio AJ, Carter JD, Piantadosi CA (2000)
Expression of heme oxygenase-1 in the lung in chronic hypoxia.
Am J Respir Cell Mol Biol 278:L806–L812
8. Cermak J, Baila J, Jacob HS, Baila G, Enright H, Nath K,
Vercellotti GM (1993) Tumor cell heme uptake induces ferritin
synthesis resulting in altered oxidant sensibility: possible role in
chemotherapy efficacy. Cancer Res 53:5308–5313
9. Choi AMK, Alam J (1996) Heme oxygenase-1: function, regu-
lation, and implication of a novel stress-inducible protein in
oxidant-induced lung injury. Am J Respir Cell Mol Biol 15:9–19
10. Conrad ME, Umbreit JN (2000) Iron absorption and transport—
an update. Am J Hematol 64:287–298
11. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI
(1997) Nitric oxide induces heme oxygenase-1 gene expression
and carbon monoxide production in vascular smooth muscle
cells. Circ Res 80:557–564
12. Eisenstein RS, Garcia-Mayolt D, Pettingellt W, Munro HM (1991)
Regulation of ferritin and heme oxygenase synthesis in rat
fibroblasts by different forms of iron translational control/iron-
regulated proteins/metabolic regulation/iron regulatory element-
binding protein/chelatable iron). Proc Nat Acad Sci USA
88:688–692
13. Ewing JF, Maines MD (1991) Rapid induction of heme oxy-
genase-1 mRNA and protein by hyperthermia in rat brain: heme
oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci USA
88:5364–5368
14. Eyssen-Hernandez R, Ladoux A, Frelin C (1996) Differential
regulation of cardiac heme oxygenase-1 and vascular endothelial
growth factor mRNA expressions by hemin, heavy metals, heat
shock and anoxia. FEBS Lett 382:229–233
15. Fogg S, Agarwal A, Nick HS, Visner GA (1999) Iron regulates
hyperoxia-dependent human heme oxygenase-1 gene expression
in pulmonary endothelial cells. Am J Respir Cell Mol Biol
20:797–804
16. Grasbeck R, Majuri R, Kouvonen I, Tenhunen R (1982) Spectral
and other studies on the intestinal haem receptor of the pig.
Biochem Biophys Acta 700:137–142
17. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T,
Sagara Y, Noguchi M (2004) Characterization of rat heme oxy-
genase-3 gene Implication of processed pseudogenes derived
from heme oxygenase-2 gene. Gene 336(2):241–250
18. Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh S,
Kingsley PD, De Domenico I, Vaughn MB, Kaplan J, Palis J,
Abkowitz JL (2008) A heme export protein is required for red blood
cell differentiation and iron homeostasis. Science 319:825–828
19. Keyse SM, Tyrrell RM (1987) Both near ultraviolet radiation and
the oxidizing agent hydrogen peroxide induce a 32-kDa stress
protein in normal human skin fibroblasts. J Biol Chem
262:14821–14825
20. Kim HP, Wang X, Galbiati F, Ryter SW, Choi AM (2004)
Caveolae compartmentalization of heme oxygenase-1 in endo-
thelial cells. FASEB J 18:1080–1089
21. Krishnamurthy P, Xie T, Schuetz JD (2007) The role of trans-
porters in cellular heme and porphyrin homeostasis. Pharmacol
Ther 114:345–358
22. Latunde-Dada GO, Simpson RJ, McKie AT (2006) Recent
advances in mammalian haem transport. Trends Biochem Sci
31:182–188
23. Lautier D, Luscher P, Tyrrell RM (1992) Endogenous glutathione
levels modulate both constitutive and UVA radiation/hydrogen
peroxide inducible expression of the human heme oxygenase
gene. Carcinogenesis 13:227–232
24. Lee PJ, Alam J, Wiegand GW, Choi AM (1996) Overexpression
of heme oxygenase-1 expression in human pulmonary epithelial
cells results in cell growth arrest and increased resistance to
hyperoxia. Proc Natl Acad Sci USA 93:10393–10398
25. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi
AM (1997) Hypoxia-inducible factor-1 mediates transcriptional
activation of the heme oxygenase-1 gene in response to hypoxia.
J Biol Chem 272:5375–5381
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein
measurement with the Folin phenol reagent. J Biol Chem
193:265–275
27. Mendiburo MJ, Flores S, Pizarro F, Arredondo M (2006) Heme
oxygenase-1 overexpression increases iron fluxes in Caco-2 cells.
Biol Res 39:195–197
28. Morse D, Choi MAK (2002) Heme oxygenase-1 the ‘‘emerging
molecule’’ has arrived. Am J Respir Cell Mol Biol 27:8–16
29. Parmley RT, Barton JC, Conrad ME, Austin RL, Holland RM
(1981) Ultraestructural cytochemistry and radioautography of
hemoglobin-iron absorption. Exp Mol Pathol 34:131–134
30. Philpott CC (2002) Molecular aspects of iron absorption:
insights into the role of HFE in hemochromatosis. Hepatology
35:993–1001
31. Pizarro F, Olivares M, Hertrampf E, Mazariegos DI, Arredondo
M (2003) Heme-iron absorption is saturable by heme-iron dose in
women. J Nutr 133:2214–2217
32. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM,
Sabath DE, Berg CL, Sassa S, Wood BL, Abkowitz JL (2004)
Identification of a human heme exporter that is essential for
erythropoiesis. Cell 118:757–766
33. Raffin SB, Woo CH, Roost KT, Price DC, Schmid R (1974)
Intestinal absorption of hemoglobin heme iron cleavage by
mucosal heme oxygenase. J Clin Invest 54:1344–1352
34. Roy CN, Enns CA (2000) Iron homeostasis: new tales from the
crypt. Blood 96:4020–4027
35. Stocker R (1990) Induction of heme oxygenase as a defense
against oxidative stress. Free Radic Res Commun 9:101–112
36. Sun Y, Rotenberg MO, Maines MD (1990) Developmental
expression of heme oxygenase isozymes in rat brain. Two HO-2
mRNAs are detected. J Biol Chem 265:8212–8217
37. Takeda A, Perry G, Abraham NG, Dwyer BE, Kuttyi RK, Lai-
tinen JT, Petersen RB, Smith MA (2000) Overexpression of heme
oxygenase in neuronal cells, the possible interaction with tau.
J Biol Chem 275:5395–5399
38. Tapia N, Arredondo M, Nunez MT (1996) Regulation of Fe
absorption by cultured intestinal epithelia (Caco-2) cell mono-
layers with varied Fe status. Am J Physiol 1271:G443–G447
39. Trakshel GM, Kutty RK, Maines MD (1986) Purification
and characterization of the major constitutive form of testicular
heme oxygenase. The noninducible isoform. J Biol Chem
261:11131–11137
40. Weintraub LR, Weinstein MB, Huser HJ, Rafal S (1968)
Absorption of hemoglobin iron: the role of a heme-splitting
substance in the intestinal mucosa. J Clin Invest 47:531–539
41. Wheby MS, Spyker DA (1981) Hemoglobin iron absorption
kinetics in the iron-deficient dog. Am J Clin Nutr 34:1686–1693
42. Wyllie JC, Kaufman MD (1982) An electron microscopy study of
heme uptake by rat duodenum. Lab Invest 47:471–476
Eur J Nutr (2011) 50:363–371 371
123